Discover open access scientific publications

Search, annotate, share and cite publications

Publications by David S. Sanford

Excellent Real-World Outcomes of Adults With Burkitt Lymphoma Treated With CODOX-M/IVAC Plus or Minus Rituximab

British Journal of Haematology

Hematology

2018

English

Three Newly Approved Drugs for Chronic Lymphocytic Leukemia: Incorporating Ibrutinib, Idelalisib, and Obinutuzumab Into Clinical Practice

Clinical Lymphoma, Myeloma and Leukemia

English

Related publications

Fertility and Social Reintegration After Modified CODOX-M/IVAC With or Without Rituximab: A Questionnaire Survey of Non-Hodgkin Lymphoma

Hematological Oncology

English

Adult Atypical Sporadic Burkitt Lymphoma Successfully Treated With Bendamustine and Rituximab

Lymphoma and Chronic Lymphocytic Leukemias

2013

English

Real‐World Adherence in Patients With Metastatic Colorectal Cancer Treated With Trifluridine Plus Tipiracil or Regorafenib

English

Frequency, Risk Factors, and Outcomes of Central Nervous System Relapse in Lymphoma Patients Treated With Dose-Adjusted EPOCH Plus Rituximab

American Journal of Hematology

Hematology

2017

English

Modified Dose Intensive R- CODOX-M/IVAC for HIV-associated Burkitt (BL) (AMC 048) Shows Efficacy and Tolerability, and Predictive Potential of IRF4/MUM1 Expression

Infectious Agents and Cancer

English

Burkitt Lymphoma With Multiorgan Involvement

International Journal of Recent Surgical and Medical Sciences

2018

English

Pcn334 - Outcomes of Peripheral T-Cell Lymphoma (Ptcl) Patients Treated in the Real World

English

Maintenance Rituximab or Observation After Frontline Treatment With Bendamustine-Rituximab for Follicular Lymphoma

British Journal of Haematology

Hematology

2018

English

Interim [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab

Journal of Clinical Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by David S. Sanford

Excellent Real-World Outcomes of Adults With Burkitt Lymphoma Treated With CODOX-M/IVAC Plus or Minus Rituximab

Three Newly Approved Drugs for Chronic Lymphocytic Leukemia: Incorporating Ibrutinib, Idelalisib, and Obinutuzumab Into Clinical Practice

Related publications

Fertility and Social Reintegration After Modified CODOX-M/IVAC With or Without Rituximab: A Questionnaire Survey of Non-Hodgkin Lymphoma

Adult Atypical Sporadic Burkitt Lymphoma Successfully Treated With Bendamustine and Rituximab

Real‐World Adherence in Patients With Metastatic Colorectal Cancer Treated With Trifluridine Plus Tipiracil or Regorafenib

Frequency, Risk Factors, and Outcomes of Central Nervous System Relapse in Lymphoma Patients Treated With Dose-Adjusted EPOCH Plus Rituximab

Modified Dose Intensive R- CODOX-M/IVAC for HIV-associated Burkitt (BL) (AMC 048) Shows Efficacy and Tolerability, and Predictive Potential of IRF4/MUM1 Expression

Burkitt Lymphoma With Multiorgan Involvement

Pcn334 - Outcomes of Peripheral T-Cell Lymphoma (Ptcl) Patients Treated in the Real World

Maintenance Rituximab or Observation After Frontline Treatment With Bendamustine-Rituximab for Follicular Lymphoma

Interim [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab